Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...

The Capping Prescription Costs Act would cap annual out-of-pocket prescription drug costs per year at $2,000 for individuals ...

Last year was a pivotal year for the pharmaceutical industry. Under the IRA’s Medicare Drug Price Negotiation Program (the ...

The Centers for Medicare and Medicaid Services (CMS) and pharmaceutical drug manufacturers are gearing up for the second ...

Following the earnings announcement, WST stock plummeted 38% due to its disappointing guidance. Over a broader timeframe, its ...

India's Glenmark Pharmaceuticals reported third-quarter profit below estimates on Friday due to bleak U.S. demand for its long-term illness drugs.

Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...

Recently, a letter to the editor I wrote was published in the Arkansas Democrat-Gazette on the subject of skyrocketing health-care costs, inclusive of rising pharmaceutical drug prices. I referenced ...

The Senate confirmed Robert F. Kennedy Jr. as secretary of the Department of Health and Human Services. Healthcare leaders ...

California Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high. But ...

The S&P 500 advanced 1.0% on Thursday, Feb. 13, as an executive order deferred the possible implementation of reciprocal ...

Kim Gillan writes, As the 119th Congress gets to work, I’m hopeful that Montana’s Congressional Delegation will prioritize and support legislation that addresses the ever-growing cost of prescription ...